AVANOS MEDICAL, INC. Update: The Acquisition Moves to the Final Stage

Avanos Medical, Inc. (NYSE: AVNS) is in the final stages of transitioning from a public company to a private business. The company has cleared all required government hurdles, confirming that its acquisition by an affiliate of American Industrial Partners (AIP) is moving forward.

Here is the latest breakdown of what this means for you as an investor.

1. What is the latest news?

Avanos and AIP announced on July 2, 2026, that they have received all necessary government approvals. The deal now only requires a final vote from Avanos stockholders and the completion of standard closing procedures.

2. What are the key dates?

• July 22, 2026: Avanos will hold a special stockholder meeting in Atlanta, Georgia. Shareholders of record as of the cutoff date are eligible to vote on the merger agreement.
• By July 27, 2026: If stockholders approve the deal and other closing conditions are met, the companies expect the transaction to finalize by this date.

3. Why is this happening?

AIP is a private equity firm that specializes in helping industrial and medical businesses grow. By going private, Avanos will no longer face the costs of public reporting or the pressure to meet quarterly earnings goals. This shift allows the company to focus entirely on its core products—such as pain management and respiratory tools—under AIP’s long-term guidance.

4. What does this mean for your investment?

• If you own stock: You should have received a proxy statement detailing the merger. If the deal closes, your shares will be canceled, and you will receive the agreed-upon cash payment for each share you own.
• For the stock: Once the deal closes, Avanos will no longer be a public company. Its stock will be delisted from the New York Stock Exchange.
• For the business: Operations will continue as usual. The company plans to keep supplying its medical devices to hospitals and clinics without interruption.

5. What should you do next?

• Review the official documents: Read the proxy statement filed with the SEC. It outlines the merger terms, the history of the deal, and the board’s recommendation. You can find this at sec.gov or the Avanos Investor Relations website.
• Understand the pricing: As the closing date approaches, the stock price typically trades slightly below the final cash payout. This small gap represents the time value of money and the minor risk that the deal might not close.
• Prepare for the payout: After the July 22nd vote and the final closing, your brokerage will automatically convert your shares into cash. You do not need to take any manual action; the exchange happens automatically through the Depository Trust Company (DTC) system.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and is not professional investment advice. Always do your own research or consult with a qualified professional before making any financial decisions.